0001778151-20-000002.txt : 20200623 0001778151-20-000002.hdr.sgml : 20200623 20200623143924 ACCESSION NUMBER: 0001778151-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200623 DATE AS OF CHANGE: 20200623 EFFECTIVENESS DATE: 20200623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Seneca Therapeutics, Inc. CENTRAL INDEX KEY: 0001778151 IRS NUMBER: 824541163 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369514 FILM NUMBER: 20981632 BUSINESS ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 484-883-9725 MAIL ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 D 1 primary_doc.xml X0708 D LIVE 0001778151 Seneca Therapeutics, Inc. 202 ST. ANDREWS COURT BLUE BELL PA PENNSYLVANIA 19422 484-883-9725 DELAWARE None None Corporation true 2018 Paul Hallenbeck 202 St. Andrews Court Blue Bell PA PENNSYLVANIA 19422 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2020-06-12 false true true true false 0 Walter Greenblatt & Associates, LLC 129291 None None 327 St. Marks Avenue Brooklyn NY NEW YORK 11238 CA CALIFORNIA CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA ME MAINE MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS true 3250000 500999 2749001 false 15 227500 true 0 Sales commissions will be $227,500 if the total offering amount is sold. 150000 true false Seneca Therapeutics, Inc. Paul Hallenbeck Paul Hallenbeck President 2020-06-22